Comparison between the pharmacokinetics of meranzin hydrate in a rat model of chronic depression and in controls following the oral administration of Chaihu-Shugan-San

Xie,Weibin; Qiu,Xinjian; Huang,Xi; Xie,Ying; Wu,Kaige; Wang,Yang; Ji,Hui; He,Juan; Ren,Ping

doi:10.3892/etm.2013.1229

October 2013 Volume 6 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October 2013 Volume 6 Issue 4

Full Size Image

Article

Comparison between the pharmacokinetics of meranzin hydrate in a rat model of chronic depression and in controls following the oral administration of Chaihu-Shugan-San

Authors:
- Weibin Xie
- Xinjian Qiu
- Xi Huang
- Ying Xie
- Kaige Wu
- Yang Wang
- Hui Ji
- Juan He
- Ping Ren
View Affiliations / Copyright

Affiliations: Department of Integrative Medicine of Traditional Chinese Medicine and Western Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Pages: 913-918
|
Published online on: July 23, 2013

https://doi.org/10.3892/etm.2013.1229
Expand metrics +

Abstract

Previous studies have shown that meranzin hydrate (MH) may be beneficial in depressive disorders. However, to the best of our knowledge, the pharmacokinetic characteristics of MH in depression have not previously been investigated. Chronic mild stress (CMS) in rats is used as a model of depression. The present study was designed to evaluate and compare the pharmacokinetics of MH in CMS and control rats following the oral administration of Chaihu‑Shugan‑San (CSS). Rats were randomly divided into CMS and control groups and blood samples were obtained following the oral administration of CSS. The quantification of MH levels in the plasma for pharmacokinetic study was achieved using a simple and rapid ultra‑performance liquid chromatography with photodiode array (UPLC‑PDA) method. Following the oral administration of CSS to CMS rats and controls, the maximum plasma concentration (Cmax) of MH was 58.66±6.64 and 57.54±12.67 ng/ml at 108.00±26.83 and 54.00±8.22 min, respectively. Compared with the value of the area under the concentration‑time curve (AUC)0‑1440 in control rats (19,896.76±1,041.95 μg·min/l), the AUC0‑1440 value was reduced in CMS rats (18,401.32±4332.65 μg·min/l). There were no significant differences in the majority of the pharmacokinetic parameters of MH, including the values for Cmax, AUC0‑1440, clearance rate (CL/F) and mean residence time (MRT0‑1440), between the CMS rats and the controls. However, the pharmacokinetic parameters showed that CMS accelerated the absorption of MH in rats following the oral administration of CSS.

View Figures

View References

1.	Lavergne F and Jay TM: A new strategy for antidepressant prescription. Front Neurosci. 4:1922010. View Article : Google Scholar : PubMed/NCBI
2.	Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ and Monteggia LM: Neurobiology of depression. Neuron. 34:13–25. 2002. View Article : Google Scholar
3.	Clerbaux T, Detry B, Geubel A, Veriter C, Liistro G, Horsmans Y and Frans A: The oxyhemoglobin dissociation curve in liver cirrhosis. Chest. 129:438–445. 2006. View Article : Google Scholar : PubMed/NCBI
4.	Xiong XY and Wang GX: The holistic treatment for depression. Medicine and Philosophy. 28:66–67. 2007.(In Chinese).
5.	Kim SH, Han J, Seog DH, Chung JY, Kim N, Hong PY and Lee SK: Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression. Life Sci. 76:1297–1306. 2005. View Article : Google Scholar : PubMed/NCBI
6.	Fan R, Huang X, Wang Y, et al: Ethnopharmacokinetic- and activity-guided isolation of a new antidepressive compound from Fructus Aurantii found in the traditional chinese medicine Chaihu-Shugan-San: a new approach and its application. Evid Based Complement Alternat Med. 2012:6075842012.PubMed/NCBI
7.	Hu SH, Huang X, Liang QH, et al: Simultaneously qualitative determination of multiple compounds in Chaihu-Shugan-San (CSS) and in rat intestine by UPLC-PDA. Journal of Medical Research. 39:42–45. 2010.(In Chinese).
8.	Qiu XJ, Huang X, Chen ZQ, et al: Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia. J Ethnopharmacol. 137:205–213. 2011. View Article : Google Scholar : PubMed/NCBI
9.	First M, Gil-Ad I, Taler M, Tarasenko I, Novak N and Weizman A: The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. J Mol Neurosci. 45:246–255. 2011. View Article : Google Scholar : PubMed/NCBI
10.	Blokland A, Lieben C and Deutz NE: Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J Psychopharmacol. 16:39–49. 2002. View Article : Google Scholar : PubMed/NCBI
11.	Porsolt RD, Bertin A and Jalfre M: Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 229:327–336. 1977.PubMed/NCBI
12.	Riviere C, Goossens L, Pommery N, Fourneau C, Delelis A and Henichart JP: Antiproliferative effects of isopentenylated coumarins isolated from Phellolophium madagascariense Baker. Nat Prod Res. 20:909–916. 2006. View Article : Google Scholar : PubMed/NCBI
13.	Rosselli S, Maggio A, Bellone G, et al: Antibacterial and anticoagulant activities of coumarins isolated from the flowers of Magydaris tomentosa. Planta Med. 73:116–120. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Huang W, Huang X, Xing Z, et al: Meranzin hydrate induces similar effect to Fructus Aurantii on intestinal motility through activation of H1 histamine receptors. J Gastrointest Surg. 15:87–96. 2011. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Comparison between the pharmacokinetics of meranzin hydrate in a rat model of chronic depression and in controls following the oral administration of Chaihu-Shugan-San

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles